A Long-term Follow-up Study in Patients Who Received BEAM-101

Clinical trial NCT07373639 · RECRUITING

Trial details

NCT number: NCT07373639
Sponsor: Beam Therapeutics Inc.
Status: RECRUITING
Study type: OBSERVATIONAL

Hemoglobinopathy Sickle Cell Disease

Start date: 2025-12-15
Primary completion: 2043-02-12
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.